BioCentury | Feb 28, 2017
Distillery Techniques

Assays and screens

...combinations -- the soluble guanylate cyclase (sGC) activator cinaciguat plus the phosphodiesterase-5 (PDE-5) inhibitor Levitra vardenafil...
...BAY 58-2667) in Phase II testing for acute heart failure. Bayer and GlaxoSmithKline plc market Levitra...
BioCentury | Dec 16, 2013
Strategy

Out in the cold

...Qnasl beclomethasone dipropionate Teva CVS PDE inhibitors (erectile dysfunction) Levitra vardenafil Bayer Both Staxyn orodispersible vardenafil...
BioCentury | Feb 2, 2012
Distillery Therapeutics

Indication: Other

...or treat noise-induced hearing loss. In rats or mice exposed to pathologically loud noise, Levitra vardenafil...
...effect of Pde-5 inhibitors on sensory hair cells and the damage to sensory neural cells. Levitra...
BioCentury | Feb 2, 2012
Distillery Therapeutics

Indication

...or treat noise-induced hearing loss. In rats or mice exposed to pathologically loud noise, Levitra vardenafil...
...effect of Pde-5 inhibitors on sensory hair cells and the damage to sensory neural cells. Levitra...
BioCentury | Oct 17, 2011
Clinical News

Levitra vardenafil 10 mg orodispersible tablets regulatory update

...The Scottish Medicines Consortium recommended the use of Bayer's Levitra vardenafil 10 mg orodispersible tablets on...
...Whitehouse Station, N.J.) market the orodispersible tablet formulation of vardenafil in the U.S. as Staxyn. Levitra...
...is available as an oral tablet for ED. Bayer AG (Xetra:BAY), Leverkusen, Germany Product: Levitra vardenafil...
BioCentury | Sep 13, 2010
Clinical News

Levitra regulatory update

...The European Commission approved an MAA for Bayer's Levitra vardenafil 10 mg orodispersible tablets to treat...
...product in the EU in November. In June, FDA approved the orodispersible tablet formulation of vardenafil...
...Bayer AG (Xetra:BAY), Leverkusen, Germany Product: Levitra ( Staxyn 10 mg ordispersible tablets - EU) vardenafil...
BioCentury | Aug 24, 2009
Clinical News

Levitra Rapid Dissolve vardenafil regulatory update

...orodispersible tablets to treat erectile dysfunction (ED). The product is a rapid-dissolving formulation of Levitra vardenafil...
...formulation in the U.S., where it will be known as Levitra Rapid Dissolve. Bayer markets Levitra...
...countries, including the EU. Bayer AG (Xetra:BAY), Leverkusen, Germany Product: Levitra Rapid Dissolve vardenafil ( Levitra...
BioCentury | Jul 31, 2008
Distillery Therapeutics

This Week in Therapeutics

...treat ED. Other marketed PDE-5 inhibitors for ED include Viagra sildenafil from Pfizer Inc., Levitra vardenafil...
BioCentury | May 29, 2008
Distillery Therapeutics

This Week in Therapeutics

...treat erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). Other marketed PDE-5 inhibitors include Levitra vardenafil...
BioCentury | Dec 17, 2007
Clinical News

Levitra vardenafil: Post-marketing study data

...In a 12-week, double-blind study in 386 evaluable men with ED and dyslipidemia, Levitra significantly increased...
...p<0.001). On SEP3, Levitra significantly increased erection rates by 67% vs. 34% for placebo (p<0.001). Levitra...
...of North America meeting in Chicago. Bayer AG (FSE:BAY), Leverkusen, Germany Product: Levitra vardenafil ( Vivanza...
Items per page:
1 - 10 of 93